Transform specimen processing for COVID testing
No specimen transfer. Expedite your SARS-CoV-2† workflow with a collection device that loads directly on the Panther® system.
Two-Step Workflow — Deliver Results Sooner
Traditional Respiratory Specimen Workflow
Reduce Labor, Costs and Risk with Fewer Steps
|
|
|
|
|
|
|
|
|
|
|
Eliminate manual specimen transfer steps
* In development and not for sale.
† The Aptima® SARS-CoV-2 assay: This test has not been FDA cleared or approved; This test has been authorized by FDA under an EUA for use by authorized laboratories; This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner,
